Mesenchymal Stem Cell: A Friend or Foe in Anti-Tumor Immunity

Area of Science:

• Immunology
• Oncology
• Stem Cell Biology

Background:

• Mesenchymal stem cells (MSCs) are multipotent cells with significant immunomodulatory capabilities.
• MSCs interact with various immune cells, influencing anti-tumor immunity.
• The tumor microenvironment (TME) plasticity of MSCs can lead to pro- or anti-tumorigenic effects.

Purpose of the Study:

• To review the molecular and cellular mechanisms of MSC-mediated modulation of anti-tumor immune responses.
• To discuss the therapeutic potential of MSCs in cancer immunotherapy.
• To explore MSCs and their exosomes as drug delivery vehicles for cancer treatment.

Main Methods:

• Literature review of current research on MSCs in cancer immunology.
• Analysis of signaling pathways governing MSC-immune cell-tumor cell interactions.
• Synthesis of findings on MSCs' dual role in tumor growth modulation.

Main Results:

• MSCs regulate dendritic cells, macrophages, T cells (CD4+ and CD8+), NK cells, MDSCs, and Tregs.
• MSCs adopt phenotypes based on TME cytokine profiles, influencing tumor progression.
• MSCs and exosomes show potential for targeted anti-cancer agent delivery.

Conclusions:

• Understanding MSC cross-talk in the TME is crucial for advancing MSC-based cancer immunotherapies.
• MSCs offer a promising therapeutic avenue for malignant diseases.
• Further research into MSC signaling pathways will facilitate clinical applications.